2 studies found for:    Hypericin
Show Display Options
Rank Status Study
1 Completed A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
Condition: HIV Infections
Intervention: Drug: Hypericin
2 Completed A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Hypericin

Indicates status has not been verified in more than two years